Press Releases, Presentations, and Reports

Successful Phase 2 vaccine trial promises long-term, low-cost protection from meningitis epidemics in Africa

Meningitis outbreaks in four African countries

The Meningitis Vaccine Project and Serum Institute of India Limited report successful Phase 1 clinical trial of new vaccine

PATH and WHO applaud $70 million award from Gates Foundation to prevent meningitis epidemics in Africa

WHO and PATH Appoint Director of Meningitis Vaccine Project

Interviews with PAG members

In December 2002, the Meningitis Vaccine Project held the first meeting of the Project Advisory Group (PAG), a group of African public health officials from meningitis belt countries who help advise MVP on its introduction strategy for conjugate vaccines. In this series of interviews, PAG members tell MVP how they view their role in the PAG, and they talk about the challenges of implementing clinical studies in Africa.

Read the interview of Professor Tagliante-Saracino.

Read the interview of Professor Ouédraogo.

Read the interview of Professor Adegbola.

Read the interview of Dr. de Medeiros.

Read the interview of Professor Nkrumah.

Read the interview of Professor Doumbo.

Read the interview of Dr. Touré-Baldé.

This page displays best in a browser that supports current web standards, but all content is accessible via any web device.